Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Raja Venkatraman, MarketSmith recommend five stocks for 20 March
On March 19, Nifty 50 and Sensex dropped over 3% due to HDFC Bank chairman's resignation and rising crude oil prices. Analysts recommend buying Ipca Laboratories, Great Eastern Shipping, Colgate Palmolive, Glenmark Pharmaceuticals, and Power Finance Corporation amid market volatility.
Cipla, GSPL among 6 stocks that hit 52-week lows; slip up to 24% in a month
Seven stocks from the BSE 500 index slipped to their 52-week lows. A 52-week low marks the lowest level a stock has traded at over the past year, and is closely tracked by traders and investors to gauge valuations and potential future price trends.
A rebound could be coming for the Dow, but the charts show it may be short lived
The Dow Jones is down nearly 8% from its peak, above its 200-day average near 46,500. Short-term oversold conditions hint at a rebound, but a major low may take weeks.
Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Stock market today: Trade setup for Nifty 50, US-Iran war, crude oil, gold, silver rates — 8 stocks to buy or sell
Stock market today: Market analysts recommend eight stocks for intraday trading, including Can Fin Homes and Emcure Pharmaceuticals, citing technical analysis and market conditions. Investors are advised to monitor geopolitical developments and market volatility closely for potential opportunities.
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Some low beta stocks shine as market volatility rises
Amidst rising market volatility and geopolitical tensions, low beta stocks are gaining prominence. Over one in four BSE 500 stocks have shown positive returns in the past month, with many exhibiting lower volatility than the broader market. Several companies with India-centric operations and strong financial growth have achieved double-digit returns across multiple periods.
Market ends sideways; Nifty settles near 25,500 level; VIX drops 3.15%
Nifty ended near the 25,500 level. Pharma, PSU bank and oil & gas shares advanced, while media, FMCG and financial services stocks declined.
Closing Bell: Sensex, Nifty end flat amid volatility; pharma, oil & gas gain, media falls
Bharat Electronics, Adani Ports, Sun Pharma, Bharti Airtel, Maruti Suzuki were among major gainers on the Sensex, while losers were Power Grid Corporation, Trent, Bajaj Finserv, HDFC Bank and Eternal. Among sectors, auto, pharma, oil & gas, PSU Bank telecom, metal added 0.4-1%, while media index shed 0.7%. Nifty Midcap index rose 0.6%, while smallcap index ended flat.
Nifty recovers 200 points from intra-day lows; IT continues outperformance | Closing Bell
Indian equities erased all the intraday losses with Nifty back above 23,500. TCS, Infosys, HCL Tech, Tech Mahindra, Trent are among top gainers on the Nifty, while losers are NTPC, Power Grid Corp, Cipla, Dr Reddy's Labs and L&T. Among sectors IT index up 4%, while auto, metal, Consumer Durables, realty up 0.5% each. However, pharma, healthcare, power, media, energy down 0.5-1%. Nifty Midcap and Smallcap indices down marginally. Catch Lovish Darad in conversation with Market Experts.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.